Nema internetske veze — prikazuje se spremljena verzija stranice.

武田薬品工業

Takeda Pharmaceutical Co Ltd ADRUSUSD
← Na Filtar Dionica

Takeda Pharmaceutical Co Ltd ADR (US:TKPHF) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 3. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

O Tvrtki

Web-Stranica
takeda.co.jp
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sjedište
TOKYO, Japan
Glavni Direktor
Julie Kim
Zaposlenici
47 029
Osnovana
1781
Dionice u Optjecaju
1.6 mlrd. na dan 2026-10-13
DatumDionicePromjena
13.10.20261.6 mlrd.—nema značajnih promjena
09.10.20261.6 mlrd.—nema značajnih promjena
08.10.20261.6 mlrd.—nema značajnih promjena
07.10.20261.6 mlrd.
Broj dionica prema izvješćima tvrtke. Podjela dionica prepoznaje se po skoku broja za cijeli broj puta.
Slobodno Prenosive Dionice
3.16 mlrd.
Tržišna Kapitalizacija
9.52 bil. JPY
Insajderi
0.07%
Institucionalni Ulagači
3.31%
Djelatnost (SIC)
Pharmaceutical Preparations
Pravni Oblik
T417
ISIN
US8740602052
LEI
549300ZLMVP4X0OGR454
Omjer Isplate
gubitak
FCF
627 mlrd. JPY
49%
Dug
4.94 bil. JPY
7.1 g. FCF
Dividendni Staž
—
Zarada, FCF i isplaćene dividende — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
Opis

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan.

oglas

Burze i Oznake

BurzaOznakaValutaCijenaVrsta
US USA StocksTKPHF OTCUSD33.85 -5.31%obične dionice
TSE Tokyo Stock Exchange4502 glavnaJPY5 963 +2.05%obične dionice
VI Vienna Stock ExchangeTKD dodatnaEUR33.01 +1.29%obične dionice

Cijena za 3 Mjeseca

dan rasta dan pada ex-dividendni datum datum isplatePrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Dividende

Godišnje, US:TKPHF: 202 JPY (2 ispl.)

Takeda Pharmaceutical Co Ltd ADR (TKPHF) isplaćuje dividende dvaput godišnje. Godišnje (12 mjeseci do uključivo posljednje najavljene isplate): 202 JPY po dionici (isplata: 2). Prema povijesti isplata, sljedeći datum ex-dividende očekuje se oko 31.03.2027.

Ex-DatumIsplataIznos%VrstaOznaka
2026-09-30—102.0000 JPY1.9/3.8 %polugodišnjiUS:TKPHF
2026-03-312026-06-25100.0000 JPY1.9/3.7 %polugodišnjiUS:TKPHF
2025-09-302025-12-01100.0000 JPY1.9/3.7 %polugodišnjiUS:TKPHF
2025-03-312025-06-2698.0000 JPY1.8/3.7 %polugodišnjiUS:TKPHF
2024-09-302024-12-0298.0000 JPY1.8/≈3.7 %polugodišnjiUS:TKPHF

Najveći Imatelji

ImateljUdioDioniceDatum Izvješća
Capital Research Global…0.6%19.3 mil.2026-06-30
AMERICAN MUTUAL FUND0.57%18.16 mil.2026-06-30
FMR, LLC0.3%9.6 mil.2026-06-30
Morgan Stanley0.22%6.99 mil.2026-06-30
Adage Capital Partners G…0.19%6.05 mil.2026-06-30
Goldman Sachs Group Inc0.16%5.13 mil.2026-06-30
Brandes Investment Partn…0.14%4.54 mil.2026-06-30
Arrowstreet Capital, Lim…0.12%3.73 mil.2026-06-30
Blackrock Inc.0.12%3.69 mil.2026-06-30
Renaissance Technologies…0.08%2.57 mil.2026-06-30
Qube Research & Technolo…0.07%2.21 mil.2026-06-30
First TRT Exch-Trd Fd.-F…0.06%1.88 mil.2026-08-31
VanEck ETF Trust-VanEck…0.06%1.79 mil.2026-08-31
Steward Funds Inc-Stewar…0.02%711 8712026-04-30
Mercer Funds-Mercer Non-…0.02%586 0982026-06-30
American Century ETF Tru…0.02%553 0082026-08-31
GOLDMAN SACHS TRUST-Gold…0.02%494 4422026-07-31
WEBER CHRISTOPHE PIERRE…≈0.01%418 8032026-04-27
KIM JULIE SO-YOUNG (Chie…≈0.01%391 4892026-08-10
Trust for Professional M…0.01%170 1132026-05-31
MUTUAL FUND SERIES TRUST…0.01%169 0002026-06-30
PLATFORD GILES RICHARD (…≈0.01%315 8382026-08-10
BITETTI TERESA MARIE (Of…≈0.01%252 0102026-08-10
FURNEY NATALIE ANNE MARI…≈0.01%204 2982026-08-10
DUPREY LAUREN RUSCKOWSKI…≈0.01%191 5222026-09-14
PACHECO RHONDA JANICE (O…≈0.01%182 5072026-08-10
PIGNAGNOLI AGOSTI MARCEL…≈0.01%176 9772026-08-10
RICCI GABRIELE (Chief Te…≈0.01%171 6542026-08-10
Carillon Series Trust-Ca…0%160 0002026-06-30
PLUMP ANDREW STEWART (Of…——2026-09-02